It looks as if AXT may have finally found some traction. The market depth is looking positive and PANR is on track. Hopefully we start to see some resemblance between the two.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025